Tag: research
-
Reporting from the British Neuro-Oncology Society
Our Research Communications & Engagement Officer, Arshiya, shares some of the most exciting highlight from the 2019 annual British Neuro-Oncology Society (BNOS) conference.
-
Announcing our funding of a major new role at The University of Manchester
We’re delighted to announce our £1.35m investment in a pioneering drive to help accelerate research into brain tumours at one of the UK’s leading universities.
-
Reporting from the American Society of Clinical Oncology
Our Research Communications & Engagement Officer, Arshiya, shares some of the most exciting results from the American Society of Clinical Oncology (ASCO) conference
-
Predicting the risk of meningioma recurrence
Our funded research has created a tool to help clinicians predict meningioma recurrence
-
Announcing our research partnership investment with CRUK
Scottish scientist set to receive over £6 million from Cancer Research UK and The Brain Tumour Charity to find new ways to treat glioblastoma, one of the hardest types of cancer to treat.
-
Analysis shows Deputax-M is unsuccessful
Deputax-M failed to meet its target overall survival during an interim analysis of a phase 3 clinical trial in glioblastoma
-
Nivolumab fails to meet its target
Nivolumab, an immunotherapy drug, has been unsuccessful in improving overall survival in a phase 3 clinical trial when tested in newly diagnosed glioblastoma with unmethylated MGMT
-
Redefining medulloblastoma
New research from one of our funded grants gives much needed insight into group 3 and 4 medulloblastoma
-
Using artificial intelligence to assess the treatment response of brain tumours
A research team from Germany has used artificial intelligence to improve the assessment of treatment response in brain tumours
-
Be part of the NHS Personal Health Budget survey
NHS England are currently running a questionnaire to find out more about people’s experiences of Personal Health Budgets, which could feed into and shape the future of personalised healthcare
-
Innovating to defeat brain tumours
We’re thrilled to be the first ever UK charity to partner with the US-based Center for Advancing Innovation (CAI), an organisation dubbed ‘Tinder for start-ups’. We’ll be co-funding a pioneering initiative coordinated by the CAI, called The Brain Race. This will ask researchers and inventors from across the world to submit innovative ideas aimed at defeating brain tumours.
-
Further research needed to identify possible warning signs of a brain tumour
Further research needed to identify possible warning signs of a brain tumouriple subtle ‘changes’ and visit their GP at least once before being diagnosed with a brain tumour
-
Partners in crime: When patients become partners in research
Arshiya reports on an event she recently attended at Addenbrookes Hospital in Cambridge, held by Mr Mike Hart, a neurosurgery registrar.
-
Announcing our new pioneering grants
As part of our commitment to increasing survival and halving the harm of brain tumours, we have committed over £1 million to transformative research
-
Breaking news for research into childhood brain tumour growth from our funded researchers
Our scientists in Heidelberg and London have discovered what drives the unpredictable growth of low grade brain tumours
-
The second blog from the Society for Neuro-oncology conference
SNO is an annual conference where those at the forefront of research to defeat brain tumours come together to share their work, discuss the progress that has been made and consider strategies for future development
-
Updates from the Society for Neuro-oncology conference
We recently represented the charity at an international scientific conference called SNO in New Orleans
-
Groundbreaking clinical trial announced today in honour of Tessa Jowell
Hundreds more brain tumour patients are set to be offered access to experimental treatments over the next five years thanks to the Tessa Jowell BRAIN-MATRIX
-
New drug discovered that could prevent the spread of glioblastoma cells
Researchers have discovered a new drug could potentially halt the spread of glioblastoma cells
-
Personalising treatments for children with medulloblastomas
Scientists identify a subgroup of children diagnosed with medulloblastoma that could be given less aggressive treatments
-
The International Symposium on Paediatric Neuro-oncology
Our Research Communications Assistant, Arshiya, gives an overview of the International Symposium on Paediatric Neuro-Oncology (ISPNO)
-
Is anti-angiogenic therapy to treat glioblastomas a viable option?
Results of two phase 2 clinical trials testing cabozantinib suggest that anti-angiogenic therapy could be used to treat glioblastomas
-
Our research update into glioblastoma, adaptive trials, and the ‘pink drink’
Our Research Engagement Manager Becky Birch, outlines developments highlighted by Tessa Jowell’s debate
-
Society for Neuro-Oncology annual meeting (part two)
Our Head of Research, Phil Hexley, outlines what happened at SNO: the 22nd Annual Meeting and Education Day of the Society for Neuro-Oncology